NASDAQ : EDSA
Edesa Biotech, Inc. — Key statistics
Healthcare · Biotechnology · Canada
Last price 2.57 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 34.72M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 33.51M |
| Enterprise Value | 23.18M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 11, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 13.51M |
| Shares Outstanding | 13.51M |
| Shares Change (YoY) | +72.33% |
| Shares Change (QoQ) | +5.46% |
| Owned by Insiders (%) | 10.46% |
| Owned by Institutions (%) | 27.21% |
| Float | 10.03M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 62.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.76 |
| Quick Ratio | 2.70 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -122.93% |
| Return on Assets (ROA) | -66.43% |
| Return on Invested Capital (ROIC) | -79.70% |
| Return on Capital Employed (ROCE) | -166.02% |
| Weighted Average Cost of Capital (WACC) | 10.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$829,528 |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 800 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.22 |
| 52-Week Price Change | +39.25% |
| 50-Day Moving Average | 3.74 |
| 200-Day Moving Average | 5.66 |
| Relative Strength Index (RSI) | 33.54 |
| Average Volume (20 Days) | 42,674 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 161,309 |
| Short Previous Month | 203,556 |
| Short % of Shares Out | 1.19% |
| Short % of Float | 1.61% |
| Short Ratio (days to cover) | 3.61 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.63M |
| Pretax Income | -14.10M |
| Net Income | -14.10M |
| EBITDA | -14.53M |
| EBIT | -14.63M |
| Earnings Per Share (EPS) | -$1.73 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 10.33M |
| Total Debt | n/a |
| Net Cash | 10.33M |
| Net Cash Per Share | $0.76 |
| Equity (Book Value) | 8.81M |
| Book Value Per Share | 0.04 |
| Working Capital | 6.87M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -8.91M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 102,844 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.91M |
| FCF Per Share | -$0.66 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -72.33% |
| Shareholder Yield | -72.33% |
| Earnings Yield | -69.84% |
| FCF Yield | -24.88% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $16.33 |
| Price Target Difference | 558.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 11, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |